183 related articles for article (PubMed ID: 18297714)
1. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
Bouzgarrou N; Hassen E; Schvoerer E; Stoll-Keller F; Bahri O; Gabbouj S; Cheikh I; Maamouri N; Mammi N; Saffar H; Trabelsi A; Triki H; Chouchane L
J Med Virol; 2008 Apr; 80(4):607-14. PubMed ID: 18297714
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity.
Bouzgarrou N; Hassen E; Farhat K; Bahri O; Gabbouj S; Maamouri N; Ben Mami N; Saffar H; Trabelsi A; Triki H; Chouchane L
Hum Immunol; 2009 Apr; 70(4):230-6. PubMed ID: 19480854
[TBL] [Abstract][Full Text] [Related]
4. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
Zhang PA; Wu JM; Li Y; Yang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
6. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.
Tanaka Y; Furuta T; Suzuki S; Orito E; Yeo AE; Hirashima N; Sugauchi F; Ueda R; Mizokami M
J Infect Dis; 2003 Jun; 187(11):1822-5. PubMed ID: 12751042
[TBL] [Abstract][Full Text] [Related]
7. CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.
Itakura J; Nagayama K; Enomoto N; Sakamoto N; Tazawa J; Izumi N; Marumo F; Sato C
J Med Virol; 2001 Jan; 63(1):22-8. PubMed ID: 11130883
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
Yee LJ; Tang J; Herrera J; Kaslow RA; van Leeuwen DJ
Genes Immun; 2000 Aug; 1(6):386-90. PubMed ID: 11196686
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease.
Migita K; Sawakami-Kobayashi K; Maeda Y; Nakao K; Kondoh S; Sugiura M; Kawasumi R; Segawa O; Tajima H; Machida M; Nakamura M; Yano K; Abiru S; Kawasaki E; Yatsuhashi H; Eguchi K; Ishibashi H
Transl Res; 2009 Feb; 153(2):91-6. PubMed ID: 19138654
[TBL] [Abstract][Full Text] [Related]
10. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
[TBL] [Abstract][Full Text] [Related]
11. The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients.
Lapiński TW
Arch Immunol Ther Exp (Warsz); 2001; 49(4):311-6. PubMed ID: 11726034
[TBL] [Abstract][Full Text] [Related]
12. Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patients.
Sermasathanasawadi R; Kato N; Muroyama R; Dharel N; Shao RX; Chang JH; Li CZ; Kawabe T; Omata M
Liver Int; 2008 Jul; 28(6):798-806. PubMed ID: 18397234
[TBL] [Abstract][Full Text] [Related]
13. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection.
Zhu C; Zhang R; Liu D; Mukhtar MM; Liu W; Peng G; Wang K; Hao Q; Xu Y; Liu F; Zhu Y; Wu J
Clin Chim Acta; 2009 Mar; 401(1-2):124-7. PubMed ID: 19083997
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
Persico M; Capasso M; Persico E; Masarone M; Renzo Ad; Spano D; Bruno S; Iolascon A
J Hepatol; 2006 Dec; 45(6):779-85. PubMed ID: 17049666
[TBL] [Abstract][Full Text] [Related]
15. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
16. Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection.
Mueller T; Mas-Marques A; Sarrazin C; Wiese M; Halangk J; Witt H; Ahlenstiel G; Spengler U; Goebel U; Wiedenmann B; Schreier E; Berg T
J Hepatol; 2004 Oct; 41(4):652-8. PubMed ID: 15464247
[TBL] [Abstract][Full Text] [Related]
17. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
[TBL] [Abstract][Full Text] [Related]
18. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
19. Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.
Suneetha PV; Goyal A; Hissar SS; Sarin SK
J Med Virol; 2006 Aug; 78(8):1055-60. PubMed ID: 16789008
[TBL] [Abstract][Full Text] [Related]
20. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
